Sequential human immunodeficiency virus (HIV) isolates, recovered from a panel of longitudinally collected peripheral blood mononuclear cells obtained from 20 initially asymptomatic HIV-seropositive homosexual men, were studied for differences in replication rate, syncytium-inducing capacity, and host range. Eleven individuals remained asymptomatic; nine progressed to acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) at the time point at which the last HIV isolate was obtained. In 16 individuals, only non-syncytium-inducing (NSI) isolates, with a host range restricted to mononuclear cells, were observed. From four individuals, high-replicating, syncytium-inducing (SI) isolates that could be transmitted to the H9, RC2A, and U937 cell lines were recovered. From two of these four individuals, SI isolates were obtained throughout the observation period. In the two others, a transition from NSI to SI HIV isolates was observed during the period of study. Three of these four individuals developed ARC or AIDS 9 to 15 months after the first isolation of an SI isolate. With the exception of the two individuals in whom a transition from NSI to SI isolates was observed, within a given individual the replication rate of sequential HIV isolates was constant. A significant correlation was found between the mean replication rate of isolates obtained from an individual and the rate of CD4+ cell decrease observed in this individual. In individuals with low-replicating HIV isolates, no significant CD4+ cell loss was observed. In contrast, recovery of high-replicating isolates, in particular when these were SI isolates, was associated with rapid decline of CD4+ cell numbers and development of ARC or AIDS. These findings indicate that variability in the biological properties of HIV isolates is one of the factors influencing the course of HIV infection.
The clinical course of infection with the human immunodeficiency virus (HIV) exhibits a remarkable degree of variability with respect to the latency period (16, 25) , occurrence of HIV antigenemia (2, 8, 12) , and clinical manifestations upon development of disease. In this study, we address the possibility that differences in pathogenic properties between HIV variants may influence the course of HIV infection. Molecular analysis of HIV isolates has demonstrated extensive genomic variability (1, 5) , especially in the enm gene region (14, 33, 38) . Although some features of the development of HIV infection have been linked to certain structural and regulatory properties of HIV isolates at the molecular level (11, 21, 31, 32) , little is known of the possible consequences of genomic variability for differences in pathogenic properties of divergent HIV strains. It is well known from studies with animal retroviruses, including lentiviruses (9, 19, 23, 27, 35) , that virus strains may exhibit such differences in virulence. For these reasons, we and others (3, 4, 7, 10, 34, 37) studied the biological properties of HIV isolates in cell culture. In a previous study on 24 transsectionally obtained HIV isolates (34) , we observed clear, reproducible differences between HIV isolates from different individuals with respect to replication rate, syncytium-inducing (SI) capacity, and host range. HIV isolates with high replication rates and SI capacity in primary isolation were found more frequently in individuals with acquired immuno-* Corresponding author. deficiency syndrome (AIDS) or AIDS-related complex (ARC) (34) .
The present study was undertaken to find out whether changes in biological characteristics of HIV isolates occur in the course of time and to obtain evidence for a possible pathogenic significance of particular viral properties from the way in which recovery of particular HIV isolates is related in time to the clinical course of HIV infection.
MATERIALS AND METHODS
Subjects. HIV isolates were recovered from 20 male homosexuals participating in a large-cohort study (8) . All subjects were seropositive and asymptomatic (Centers for Disease Control stage II or III) at the beginning of the observation period.
Virus isolation. Mononuclear cells (MNC) were obtained from heparinized venous blood by isolation on a Percoll density gradient and cryopreserved until use. For HIV isolation, MNC (3.5 x 106) from seropositive individuals were cocultivated with 2.5 x 106 2-day phytohemagglutininprestimulated MNC from healthy seronegative blood donors. All isolations were performed in duplicate. To be able to compare data obtained from different isolations, MNC of one blood donor were used in all isolations; duplicate cocultivations were performed with MNC of various blood donors. Cells were cultured under conditions described previously (34) . Three times a week, cultures were checked for syncytium formation. Each time, at least ten microscope fields (magnification, x 100) per culture were observed. Twice a week, starting on day 4, cells were pelleted and supernatants were polyethylene glycol precipitated (PEG 6000; final concentration, 7.5%) for testing in reverse transcriptase (RT) and HIV p24 antigen capture assays. Once a week, fresh 2-day phytohemagglutinin-stimulated MNC from a healthy blood donor were added. A culture was considered positive for HIV when at least two successive supernatants were found to be positive (i.e., over three times the negative control) in antigen capture or RT assays. Cultures were maintained up to a maximum of 35 days, unless virus was recovered before. RT activity was measured as described previously (34) . HIV p24 was detected in a radioimmunoassay (Tersmette et al., submitted for publication). Briefly, HIV p24 was captured by rabbit anti-HIV immunoglobulin G coupled to Sepharose beads and detected by a 125I-labeled monoclonal antibody directed to HIV p24.
Transmission to cell lines. Transmission of HIV isolates to H9, a CD4+ T-cell line, and U937 (26) and RC2A (6) , both CD4+ promonocytic cell lines, was attempted by both inoculation with cell-free culture supernatants and cocultivation (34) .
Determination of CD4+ cell numbers. CD42+ cell numbers were determined at 3-month intervals by cytofluorography as described previously (22) . For the analysis of CD4+ cell decline, the three-point moving average of the absolute CD4+ cell numbers was calculated. The CD4+ cell decline per year was expressed as a percentage of the initial CD4+ cell number. In two persons with biphasic curves (subjects 2 and 10), the highest three-point average, occurring 9 A remarkably constant replication rate was observed when isolates from one individual were compared, except for isolates from subjects 1 and 2, which will be dealt with below. The duplicate cocultivations gave comparable results (not shown), in agreement with previous experiments (34) . In contrast, clear differences in replication rate were observed between isolates obtained from different individuals (Table 1) . Previously, we showed that differences in HIV replication rate in an MNC culture can still be observed when comparable numbers of cells infected with different HIV isolates are used as an inoculum (34) . To further exclude that the differences in day of detection of viral replication resulted from differences in number of infected patient cells, we studied the effect of absolute number of infected cells upon the rapidity of virus detection. In two experiments, titration of patient cells in our isolation protocol did not result in a significant decrease of rapidity of virus detection (Table 2 ), providing further proof that this parameter reflects a specific property of a virus isolate.
Only a minority of HIV isolates was able to induce syncytia. This property was observed for all isolates obtained from subjects 3 and 10 and the last four isolates of subjects 1 and 2 (see below). SI isolates had a significantly higher mean replication rate compared with non-SI (NSI) isolates (P = 0.005; Fig. 1A ). As observed previously (34) , a strong correlation existed between SI capacity and the ability to replicate in the H9 cell line (Tables 1 and 3 g Conversion for serum HIV p24 in the course of the period of observation (see Table 2 ).
" Azidothymidine treatment was begun at the end of the period of observation. phenotypic switch occurred, the properties of sequential isolates remained stable over time, we investigated the relation between the occurrence of specific variants of HIV and the clinical outcome of HIV infection. In this panel, again, SI isolates were obtained more frequently from individuals who progressed to ARC or AIDS (3 of 9) than in persons who remained asymptomatic (1 of 11) . A significantly higher rate of CD4+ cell decrease (P < 0.001) was seen in individuals from whom SI isQlates were recovered compared with that in individuals who yielded NSI isolates (Fig. 1B) .
Comparison of the mean replication rate of a set of isolates from an individual with the clinical outcomne revealed a significant difference between the replication rates of isolates from individuals who progressed to ARC or AIDS and individuals who remained asymptomatic (P < 0.05) (Fig.  1C) . Moreover, a significant correlation was observed between the mean first day of detection in the antigen capture assay of a set of sequential isolates from an individual and both the outcome of CD4+ cell count and rate of CD4+ cell decrease observed in this individual (p = 0.81, P < 0.001, and p = 0.85, P < 0.001, respectively, in the Spearman rank order test) ( Fig. 2A and B) .
A similar, highly significant correlation was found between both the rate of CD4+ cell decrease and final CD4+ cell count and two other parameters of virus replication rate, i.e., mean first day of detection in the RT assay and mean day of peak RT activity (P < 0.001 for both parameters; data not shown). Since sequential isolates from an individual were generally found to have constant replication rates in primary isolation, in this group the rate of CD4+ cell decrease and the outcome of CD4+ cell count can apparently be related to the replication rate of HIV isol4tes recovered at the beginning of the study period.
Switch of biological properties of HIV isolates with subsequent development of disease. Sequential data from the four individuals from whom SI isolates were recovered are summarized in Table 3 a period of 18 to 27 months. In this period, five to eight isolates per individual were obtained. In two of these individuals (subjects 3 and 10), in whom virus isolation was successful in all but the first MNC sample studied, all isolates obtained were SI isolates. Interestingly, in the other two individuals (subjects 1 and 2), a transition from NSI to SI isolates was observed. In these subjects, the NSI isolates preceding the SI isolates had a slightly lower mean replication rate, which was only observed when judged by day of appearance of RT activity and peak RT activity (not shown). Concomitant with the development of SI capacity, a broadening of host range occurred (Table 3) . A gradual transition was suggested by the finding that transmission of early SI isolates from subjects 2 and 10 was relatively inefficient and required a prolonged time of culture before viral replication became detectable. Also, in preliminary experiments, SI isolates could be transmitted from the H9 cell line to the U937 and RC2A cell lines, but only SI isolates obtained at later time points could be transmitted to these cell lines directly from MNC culture (data not shown).
In all four individuals, recovery of SI isolates with a broad host range was followed by a rapid decline of CD4+ cell numbers. ARC or AIDS ensued in three of these individuals. The one individual (subject 10) of these four who remained asymptomatic converted for serum HIV antigen during the period of observation (Table 3) . During the last 3 months of In most cases, recovery of SI isolates was accompanied by the detection of serum HIV antigen (subject 3) or conversion for serum HIV antigen during the observation period (subjects 2 and 4) ( Table 3) . In subject 1, serum HIV antigen was not detectable, but only low levels of anti-p24 antibodies (titers l1:8) were detected, possibly reflecting clearance of these antibodies by elevated production of HIV p24 (20) .
Molecular analysis of the isolates obtained from subject 3 demonstrated a high degree of similarity among these isolates, although some differences could also be demonstrated (Fig. 3) . All isolates from subject 3 Apparently, a spectrum from low-to high-replicating HIV viruses exists, with SI isolates having the highest replication rates. In contrast to the gradual differences in replication rate, there is a clear distinction between SI and NSI isolates with respect to their ability to replicate in the permanent cell lines tested. At present, it is not clear whether the infectivity block for NSI isolates in these cell lines is absolute, although our complete failure to transmit NSI isolates to these cell lines in numerous attempts both by infection with cell-free virus and cocultivation seems to indicate that this is the case.
Previously, we showed that the high replication rate of SI isolates observed in primary isolation reflects the rapid spread of these isolates in an MNC culture compared with that of low-replicating NSI isolates (34), presumably indicating a higher infectivity. Envelope variability seems to be the most likely explanation for both differences in infectivity and SI capacity. It has been shown that amino acid substitution (18) or modification of glycosylation (13) may substantially affect the SI capacity of HIV isolates. Mutational analysis of the 3' open reading frame region pointed out that variation in this gene might also be responsible for the differences in SI capacity and replication rate observed (11, 21) . Possibly, due to less efficient binding and fusion capacity, NSI variants have a need for cellular factors other than CD4 for penetration and uncoating which are lacking in the cell lines tested. Alternatively, the difference in cellular tropism between SI and NSI variants could be due to differences in the long terminal repeat, resulting in a differential sensitivity to cellular transcriptional activators (17, 24 In a previous transsectional study, we showed that SI isolates are observed more often in patients with AIDS or ARC (34) . In the present study, we demonstrate that in individuals with AIDS or ARC who yielded SI isolates, SI isolates were already present 9 to 15 months before development of the disease. Moreover, first isolation of an SI isolate was always followed by a rapid decline of CD4+ cells. All features of SI isolates can well be imagined to represent determinants of virulence in vivo. Therefore, it seems likely that appearance of these isolates is causally related to the subsequent CD4+ cell loss and development of the disease. The SI capacity and the apparent broader host range of these isolates seem to fit well with the hypothesis (30) according to which syncytium formation of long-living, low-CD4-expressing, HIV-infected cells with high-CD4-expressing cells may be an efficient mechanism to accomplish CD4+ cell depletion. Nevertheless, SI isolates are not observed in all individuals who develop ARC or AIDS. Therefore, it is of particular interest that a significant correlation exists between both the CD4+ cell decrease and outcome of the CD4+ cell numbers of an individual at the end of the period of observation and the (mean) replication rate of the sequential isolates obtained from this individual. The most rapid decline in CD4+ cell numbers was observed in the individuals from whom SI isolates were recovered, followed by those from whom high-replicating NSI isolates were obtained. In five clinically stable asymptomatic individuals from whom slow-replicating NSI isolates were obtained, no significant CD4+ cell decrease was observed over a 15-to 31-month period. Thus, it seems that the replication rate of an HIV isolate is directly associated with the decrease in CD4+ cell numbers in the subsequent period. Next to decrease of CD4+ cell counts, HIV p24 antigenemia has been used as a clinical marker for progression of disease (2, 8, 12) . Although in this study antigenemia or low titers of antibodies to p24 coincided in most cases with high virus replication in vitro, two individuals, who remained asymptomatic in spite of existence of antigenemia for 15 months, did not demonstrate significant CD4+ cell loss over this period and yielded consistently low-replicating HIV isolates. Therefore, the precise nature of the relationship between HIV p24 antigenemia and in vitro virus replication rates remains to be elucidated.
Recently, the degree of genomic variability of HIV clones obtained from one person at the same or different time points has been estimated (mean predicted nucleotide differences, 2 and 4%, respectively) (29) . The result of the molecular analysis of the isolates of subject 3 are in agreement with these observations. This degree of genomic variability, however, does not appear to affect the stability of the biological phenotype of sequential isolates studied here. Also, the relation found between the occurrence of particular virus variants and clinical course in itself indicates that the in vitro biological properties of these isolates are relevant to the in vivo situation.
The results of this study are compatible with the hypothesis that differences in the rate of CD4+ cell decrease observed between individuals, presumably one of the main determinants for the variation in the latency period of HIV infection, may be caused by differences in virulence between HIV variants. In this study, we could not find evidence for the gradual development of high-replicating NSI variants from low-replicating NSI variants. Nevertheless, such a development early in infection, possibly under the influence of host factors, cannot be excluded, because the individuals studied here were all seropositive at the beginning of the observation period. In two individuals, who eventually developed AIDS or ARC, a switch from high-replicating NSI isolates to SI isolates with still higher replication rates was observed 9 to 15 months before the onset of disease. Recently, a similar finding in two seropositive individuals has been reported (7) . Theoretically, such a phenotypic switch could result from either mutational changes or superinfection with an SI isolate. The gradual changes occurring in the isolates from subjects 2 and 10 and the fact that superinfection with a second HIV isolate until now has not been demonstrated in humans (15) 
